From: Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy
Agent | Class | Target | References |
---|---|---|---|
Bevacuzimab | MAB | VEGF-A | |
IMC-1121B | MAB | VEGFR-2 | [19] |
CDP-791 | DiFabPEG | VEGFR-2 | [20] |
CEP-7055 | TKI | VEGFR-1,2,3 | [20] |
PTK-787 | TKI | VEGFR-1,2 | [21] |
AEE788 | TKI | VEGFR-2, EGFR | [22] |
ZD6474 | TKI | VEGFR-1,2,3, EGFR | [23] |
AG013736 | TKI | VEGFR-1,2 | [24] |
AZD2171 | TKI | VEGFR-1,2 | [25] |
SUO11248 | TKI | VEGFR-1,2, PDGFR | [26] |
CP-547,632 | TKI | VEGFR-1,2 | [27] |
GW786024 | TKI | VEGFR-1,2,3 | [28] |
Bay 93-4006 | TKI | VEGFR-1,2, PDGFR | [29] |
AMG 706 | TKI | VEGFR-1,2,3 | [30] |